Fundraising Fox

Encentrio Therapeutics, Inc.

San Francisco, US · Founded 2023 · Delaware corporation · 1 known investors

Biotech

Founders & leadership

TH
Thomas HechtDirector
SL
Sung LeeExecutive Officer, Director
JF
Johanna Friedl-NadererDirector
NS
Natascha SchillExecutive Officer, Director
VD
Vanina de VerneuilExecutive Officer
GS
George ScangosDirector

Investors · 1

ARCH Venture PartnersreportedChicago · $50K – $250Mvia George Scangos · board

Reported raises · per SEC filings

Form D private placements
▶$400KraisedApr 2023 · 1 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Thomas HechtDirector
  • George ScangosDirector
  • Sung LeeExecutive Officer, Director
  • Johanna Friedl-NadererDirector
  • Natascha SchillExecutive Officer, Director
  • Vanina de VerneuilExecutive Officer
Offering amount
$400K
Amount sold
$400K
First sale
Mar 2023
Incorporated
Corporation, Delaware, 2023
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.